Introduction: The current pandemic by the SARS-CoV-2 has affected the world's general population. While the predominant presentation is with respiratory disease, neurological complications are increasingly recognized. Post-infectious immune-mediated disorders such as Guillain Barré syndrome and Myasthenia Gravis (MG) have been described.Case presentation: We report a case with an unusual presentation of myasthenia gravis after a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection . We also present a retrospective review of the literature of all the reported cases of de novo myasthenia gravis associated with SARS-CoV2 infection from march-2020 to april-2021. Conclusion: Myasthenia gravis could also be the result of an autoimmune reaction triggered by SARS-CoV-2 infection.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.